UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases

European journal of clinical pharmacology, 2018-02, Vol.74 (2), p.161-169

2018

Volltextzugriff (PDF)

Complete Early Reversal of Diffusion-Weighted Imaging Hyperintensities After Ischemic Stroke Is Mainly Limited to Small Embolic Lesions

Stroke (1970), 2013-04, Vol.44 (4), p.1043-1048

2013

Volltextzugriff (PDF)

Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002567

2022

Volltextzugriff (PDF)

Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response

Annals of the rheumatic diseases, 2021-10, Vol.80 (10), p.1361-1362

2021

Volltextzugriff (PDF)

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

Annals of the rheumatic diseases, 2022-06, Vol.81 (6), p.881-888

2022

Volltextzugriff (PDF)

Therapeutic antibodies in rheumatology

Zeitschrift für Rheumatologie, 2024-03, Vol.83 (2), p.98-104

2024

Volltextzugriff (PDF)

Silent New DWI Lesions within the First Week after Stroke

Cerebrovascular diseases (Basel, Switzerland), 2012-01, Vol.33 (3), p.248-254

2012

Volltextzugriff (PDF)

Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients

Journal of autoimmunity, 2023-02, Vol.135, p.102996-102996, Article 102996

2023

Volltextzugriff (PDF)

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis

Neurology and therapy, 2024-09

2024

Volltextzugriff (PDF)

Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple’s disease

Rheumatology advances in practice, 2023-07, Vol.7 (2), p.rkad060

2023

Volltextzugriff (PDF)

Early New Diffusion-Weighted Imaging Lesions Appear More Often in Stroke Patients With a Multiple Territory Lesion Pattern

Stroke (1970), 2013-08, Vol.44 (8), p.2200-2204

2013

Volltextzugriff (PDF)

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002650

2022

Volltextzugriff (PDF)

Incidence of New Diffusion-Weighted Imaging Lesions Outside the Area of Initial Hypoperfusion Within 1 Week After Acute Ischemic Stroke

Stroke (1970), 2012-10, Vol.43 (10), p.2654-2658

2012

Volltextzugriff (PDF)

Therapeutische Antikörper in der Rheumatologie

Zeitschrift für Rheumatologie, 2024-03, Vol.83 (2), p.98-104

2024

Volltextzugriff (PDF)

Head-to-head studies on psoriasis and psoriatic arthritis

Zeitschrift für Rheumatologie, 2024-10, Vol.83 (8), p.634

2024

Volltextzugriff (PDF)

Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple's disease

Rheumatology advances in practice, 2023, Vol.7 (2), p.rkad060-rkad060

2023

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)
Berichte
(1)

Sprache

Englisch
(14)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases

Complete Early Reversal of Diffusion-Weighted Imaging Hyperintensities After Ischemic Stroke Is Mainly Limited to Small Embolic Lesions

Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series

Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

Therapeutic antibodies in rheumatology

Silent New DWI Lesions within the First Week after Stroke

Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis

Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple’s disease

Early New Diffusion-Weighted Imaging Lesions Appear More Often in Stroke Patients With a Multiple Territory Lesion Pattern

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Incidence of New Diffusion-Weighted Imaging Lesions Outside the Area of Initial Hypoperfusion Within 1 Week After Acute Ischemic Stroke

Therapeutische Antikörper in der Rheumatologie

Head-to-head studies on psoriasis and psoriatic arthritis

Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple's disease

Suchergebnisse filtern